Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study
COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has increased and clinical features for a rigorous analysis still need to be determined. Thus, we evaluated the clinical characteristics in CPE and the...
Saved in:
| Published in | Internal and emergency medicine Vol. 18; no. 7; pp. 1981 - 1993 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cham
Springer International Publishing
01.10.2023
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1828-0447 1970-9366 1970-9366 |
| DOI | 10.1007/s11739-023-03383-9 |
Cover
| Abstract | COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has increased and clinical features for a rigorous analysis still need to be determined. Thus, we evaluated the clinical characteristics in CPE and the immune infiltration that occurred. Between January 1 and December 31, 2021, 38 patients were affected by CPE (9 ICU, 19 males/19 females, 70.18 ± 11.24 years) out of 459 COVID-19 cases. Controls were subjects who were evaluated for PE between January 1 2015, and December 31, 2019 (92 patients, 9 ICU, 48 males/45 females, 69.55 ± 16.59 years). All patients underwent complete physical examination, pulmonary computed tomography, laboratory tests, D-dimer, and blood gas analysis. There were no differences in laboratory tests or D-dimer. In patients with CPE, pO2, alveolar–arterial oxygen difference (A-aDO2), oxygen saturation %, and the ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, were significantly increased. There were no differences in PaCO2. Platelet count was inversely correlated to P/F (
r
= − 0.389,
p
= 0.02) but directly to A-aDO2 (
r
= 0.699,
p
= 0.001) only in patients with CPE. Histology of lung biopsies (7 CPE/7 controls) of patients with CPE showed an increase in CD15
+
cells, HMGB1, and extracellular MPO as a marker of NETosis, while no significant differences were found in CD3
+
, CD4
+
, CD8
+
, and intracellular MPO. Overall, data suggest that CPE has a different clinical setting. Reduced oxygen content and saturation described in Patients with CPE should not be considered a trustworthy sign of disease. Increased A-aDO2 may indicate that CPE involves the smallest vessels as compared to classical PE. The significant difference in NETosis may suggest the mechanism related to thrombi formation. |
|---|---|
| AbstractList | COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has increased and clinical features for a rigorous analysis still need to be determined. Thus, we evaluated the clinical characteristics in CPE and the immune infiltration that occurred. Between January 1 and December 31, 2021, 38 patients were affected by CPE (9 ICU, 19 males/19 females, 70.18 ± 11.24 years) out of 459 COVID-19 cases. Controls were subjects who were evaluated for PE between January 1 2015, and December 31, 2019 (92 patients, 9 ICU, 48 males/45 females, 69.55 ± 16.59 years). All patients underwent complete physical examination, pulmonary computed tomography, laboratory tests, D-dimer, and blood gas analysis. There were no differences in laboratory tests or D-dimer. In patients with CPE, pO2, alveolar–arterial oxygen difference (A-aDO2), oxygen saturation %, and the ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, were significantly increased. There were no differences in PaCO2. Platelet count was inversely correlated to P/F (r = − 0.389, p = 0.02) but directly to A-aDO2 (r = 0.699, p = 0.001) only in patients with CPE. Histology of lung biopsies (7 CPE/7 controls) of patients with CPE showed an increase in CD15+ cells, HMGB1, and extracellular MPO as a marker of NETosis, while no significant differences were found in CD3+, CD4+, CD8+, and intracellular MPO. Overall, data suggest that CPE has a different clinical setting. Reduced oxygen content and saturation described in Patients with CPE should not be considered a trustworthy sign of disease. Increased A-aDO2 may indicate that CPE involves the smallest vessels as compared to classical PE. The significant difference in NETosis may suggest the mechanism related to thrombi formation. COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has increased and clinical features for a rigorous analysis still need to be determined. Thus, we evaluated the clinical characteristics in CPE and the immune infiltration that occurred. Between January 1 and December 31, 2021, 38 patients were affected by CPE (9 ICU, 19 males/19 females, 70.18 ± 11.24 years) out of 459 COVID-19 cases. Controls were subjects who were evaluated for PE between January 1 2015, and December 31, 2019 (92 patients, 9 ICU, 48 males/45 females, 69.55 ± 16.59 years). All patients underwent complete physical examination, pulmonary computed tomography, laboratory tests, D-dimer, and blood gas analysis. There were no differences in laboratory tests or D-dimer. In patients with CPE, pO2, alveolar–arterial oxygen difference (A-aDO2), oxygen saturation %, and the ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, were significantly increased. There were no differences in PaCO2. Platelet count was inversely correlated to P/F ( r = − 0.389, p = 0.02) but directly to A-aDO2 ( r = 0.699, p = 0.001) only in patients with CPE. Histology of lung biopsies (7 CPE/7 controls) of patients with CPE showed an increase in CD15 + cells, HMGB1, and extracellular MPO as a marker of NETosis, while no significant differences were found in CD3 + , CD4 + , CD8 + , and intracellular MPO. Overall, data suggest that CPE has a different clinical setting. Reduced oxygen content and saturation described in Patients with CPE should not be considered a trustworthy sign of disease. Increased A-aDO2 may indicate that CPE involves the smallest vessels as compared to classical PE. The significant difference in NETosis may suggest the mechanism related to thrombi formation. COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has increased and clinical features for a rigorous analysis still need to be determined. Thus, we evaluated the clinical characteristics in CPE and the immune infiltration that occurred. Between January 1 and December 31, 2021, 38 patients were affected by CPE (9 ICU, 19 males/19 females, 70.18 ± 11.24 years) out of 459 COVID-19 cases. Controls were subjects who were evaluated for PE between January 1 2015, and December 31, 2019 (92 patients, 9 ICU, 48 males/45 females, 69.55 ± 16.59 years). All patients underwent complete physical examination, pulmonary computed tomography, laboratory tests, D-dimer, and blood gas analysis. There were no differences in laboratory tests or D-dimer. In patients with CPE, pO2, alveolar–arterial oxygen difference (A-aDO2), oxygen saturation %, and the ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, were significantly increased. There were no differences in PaCO2. Platelet count was inversely correlated to P/F (r = − 0.389, p = 0.02) but directly to A-aDO2 (r = 0.699, p = 0.001) only in patients with CPE. Histology of lung biopsies (7 CPE/7 controls) of patients with CPE showed an increase in CD15+ cells, HMGB1, and extracellular MPO as a marker of NETosis, while no significant differences were found in CD3+, CD4+, CD8+, and intracellular MPO. Overall, data suggest that CPE has a different clinical setting. Reduced oxygen content and saturation described in Patients with CPE should not be considered a trustworthy sign of disease. Increased A-aDO2 may indicate that CPE involves the smallest vessels as compared to classical PE. The significant difference in NETosis may suggest the mechanism related to thrombi formation. COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has increased and clinical features for a rigorous analysis still need to be determined. Thus, we evaluated the clinical characteristics in CPE and the immune infiltration that occurred. Between January 1 and December 31, 2021, 38 patients were affected by CPE (9 ICU, 19 males/19 females, 70.18 ± 11.24 years) out of 459 COVID-19 cases. Controls were subjects who were evaluated for PE between January 1 2015, and December 31, 2019 (92 patients, 9 ICU, 48 males/45 females, 69.55 ± 16.59 years). All patients underwent complete physical examination, pulmonary computed tomography, laboratory tests, D-dimer, and blood gas analysis. There were no differences in laboratory tests or D-dimer. In patients with CPE, pO2, alveolar-arterial oxygen difference (A-aDO2), oxygen saturation %, and the ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, were significantly increased. There were no differences in PaCO2. Platelet count was inversely correlated to P/F (r = - 0.389, p = 0.02) but directly to A-aDO2 (r = 0.699, p = 0.001) only in patients with CPE. Histology of lung biopsies (7 CPE/7 controls) of patients with CPE showed an increase in CD15+ cells, HMGB1, and extracellular MPO as a marker of NETosis, while no significant differences were found in CD3+, CD4+, CD8+, and intracellular MPO. Overall, data suggest that CPE has a different clinical setting. Reduced oxygen content and saturation described in Patients with CPE should not be considered a trustworthy sign of disease. Increased A-aDO2 may indicate that CPE involves the smallest vessels as compared to classical PE. The significant difference in NETosis may suggest the mechanism related to thrombi formation.COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has increased and clinical features for a rigorous analysis still need to be determined. Thus, we evaluated the clinical characteristics in CPE and the immune infiltration that occurred. Between January 1 and December 31, 2021, 38 patients were affected by CPE (9 ICU, 19 males/19 females, 70.18 ± 11.24 years) out of 459 COVID-19 cases. Controls were subjects who were evaluated for PE between January 1 2015, and December 31, 2019 (92 patients, 9 ICU, 48 males/45 females, 69.55 ± 16.59 years). All patients underwent complete physical examination, pulmonary computed tomography, laboratory tests, D-dimer, and blood gas analysis. There were no differences in laboratory tests or D-dimer. In patients with CPE, pO2, alveolar-arterial oxygen difference (A-aDO2), oxygen saturation %, and the ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, were significantly increased. There were no differences in PaCO2. Platelet count was inversely correlated to P/F (r = - 0.389, p = 0.02) but directly to A-aDO2 (r = 0.699, p = 0.001) only in patients with CPE. Histology of lung biopsies (7 CPE/7 controls) of patients with CPE showed an increase in CD15+ cells, HMGB1, and extracellular MPO as a marker of NETosis, while no significant differences were found in CD3+, CD4+, CD8+, and intracellular MPO. Overall, data suggest that CPE has a different clinical setting. Reduced oxygen content and saturation described in Patients with CPE should not be considered a trustworthy sign of disease. Increased A-aDO2 may indicate that CPE involves the smallest vessels as compared to classical PE. The significant difference in NETosis may suggest the mechanism related to thrombi formation. |
| Author | Ria, Roberto Marcante, Stefano Ingravallo, Giuseppe Introna, Francesco Vacca, Antonio Sablone, Sara Grasso, Salvatore Maiorano, Eugenio Desantis, Vanessa Albanese, Federica Marozzi, Marialuisa Sveva Brosolo, Gabriele Lauletta, Gianfranco Cicco, Sebastiano Dalfino, Lidia Magistro, Arianna Cazzato, Gerardo Cicco, Gerolamo Pappagallo, Fabrizio Susca, Nicola Solimando, Antonio Giovanni Sechi, Leonardo Alberto Cariddi, Christel Catena, Cristiana |
| Author_xml | – sequence: 1 givenname: Sebastiano surname: Cicco fullname: Cicco, Sebastiano organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari – sequence: 2 givenname: Antonio surname: Vacca fullname: Vacca, Antonio organization: Division of Internal Medicine, Department of Medicine, University of Udine – sequence: 3 givenname: Federica surname: Albanese fullname: Albanese, Federica organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari – sequence: 4 givenname: Nicola surname: Susca fullname: Susca, Nicola organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari – sequence: 5 givenname: Vanessa surname: Desantis fullname: Desantis, Vanessa organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), Pharmacology Section, University of Bari Aldo Moro Medical School – sequence: 6 givenname: Arianna surname: Magistro fullname: Magistro, Arianna organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari – sequence: 7 givenname: Gerardo surname: Cazzato fullname: Cazzato, Gerardo organization: Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), Section of Pathology, University of Bari Aldo Moro – sequence: 8 givenname: Gerolamo surname: Cicco fullname: Cicco, Gerolamo organization: Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia – sequence: 9 givenname: Sara surname: Sablone fullname: Sablone, Sara organization: Department of Interdisciplinary Medicine, Section of Forensic Medicine, University of Bari Aldo Moro – sequence: 10 givenname: Christel surname: Cariddi fullname: Cariddi, Christel organization: Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), Section of Anesthesiology and Intensive Care, Ospedale Policlinico, University of Bari Aldo Moro – sequence: 11 givenname: Marialuisa Sveva surname: Marozzi fullname: Marozzi, Marialuisa Sveva organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari – sequence: 12 givenname: Cristiana surname: Catena fullname: Catena, Cristiana organization: Division of Internal Medicine, Department of Medicine, University of Udine – sequence: 13 givenname: Gabriele surname: Brosolo fullname: Brosolo, Gabriele organization: Division of Internal Medicine, Department of Medicine, University of Udine – sequence: 14 givenname: Stefano surname: Marcante fullname: Marcante, Stefano organization: Division of Internal Medicine, Department of Medicine, University of Udine – sequence: 15 givenname: Giuseppe surname: Ingravallo fullname: Ingravallo, Giuseppe organization: Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), Section of Pathology, University of Bari Aldo Moro – sequence: 16 givenname: Lidia surname: Dalfino fullname: Dalfino, Lidia organization: Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), Section of Anesthesiology and Intensive Care, Ospedale Policlinico, University of Bari Aldo Moro – sequence: 17 givenname: Gianfranco surname: Lauletta fullname: Lauletta, Gianfranco organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari – sequence: 18 givenname: Fabrizio surname: Pappagallo fullname: Pappagallo, Fabrizio organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari – sequence: 19 givenname: Antonio Giovanni orcidid: 0000-0002-2293-9698 surname: Solimando fullname: Solimando, Antonio Giovanni email: antonio.solimando@uniba.it organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari – sequence: 20 givenname: Salvatore surname: Grasso fullname: Grasso, Salvatore organization: Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), Section of Anesthesiology and Intensive Care, Ospedale Policlinico, University of Bari Aldo Moro – sequence: 21 givenname: Eugenio surname: Maiorano fullname: Maiorano, Eugenio organization: Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), Section of Pathology, University of Bari Aldo Moro – sequence: 22 givenname: Francesco surname: Introna fullname: Introna, Francesco organization: Department of Interdisciplinary Medicine, Section of Forensic Medicine, University of Bari Aldo Moro – sequence: 23 givenname: Leonardo Alberto surname: Sechi fullname: Sechi, Leonardo Alberto organization: Division of Internal Medicine, Department of Medicine, University of Udine – sequence: 24 givenname: Roberto surname: Ria fullname: Ria, Roberto organization: COVID Section, Unit of Internal Medicine “Guido Baccelli”, Department of Precision and Regenerative Medicine and Ionian Area–(DiMePRe-J), U.O.C. Medicina Interna “Guido Baccelli”, University of Bari Aldo Moro, Policlinico di Bari |
| BookMark | eNqNUMtu3CAUtapEzaP9ga6QuunGLRgw0E1VTV8jRcom7RZdYzxDimEKdqrZ9NvLPKQoWURZIBDnde-5qE5CDLaq3hD8nmAsPmRCBFU1bmiNKZW0Vi-qc6IErhVt25Pylo2sMWPirLrI-RZjzlsiXlZnVHDVEMrPq3_LcZyDRb3L05w6CMYib6HPaIpoM_sxBkhbZMcuepdH5AJaXP9afqmJQmNMFk1rCMh4yNkZ8Ci5_BsNYKaY8kcEBXFhD0Do0bqERB9X-4-S129fVacD-GxfH-_L6ue3rzeLH_XV9ffl4vNVbRhvprolsu05s13fKTYMnZAdBs7KaSQjsjfQKtz0MAwtNLLFg1DGSCmYpVYAN_SyogffOWxg-xe815vkxrKaJljv2tSHNnVpU-_b1KqoPh1Um7kbbW9smBLcKyM4_RAJbq1X8a4YckYlFsXh3dEhxT-zzZMeXTbWewg2zlk3klPFhKK7sLePqLdxTqG0UlgCc8GEYIXVHFgmxZyTHZ63h3wkMm6CycXd1M4_LT0Wl0tOWNl0P9UTqv9iacyK |
| CitedBy_id | crossref_primary_10_7759_cureus_48659 crossref_primary_10_1186_s12959_025_00692_1 crossref_primary_10_3389_fcvm_2023_1280625 crossref_primary_10_1016_j_fbio_2024_103856 |
| Cites_doi | 10.1159/000518914 10.1016/j.phrs.2020.104950 10.1016/j.echo.2020.10.009 10.1016/j.cpcardiol.2021.100819 10.4187/respcare.05433 10.1016/S0140-6736(20)30937-5 10.1093/eurheartj/ehz405 10.1007/s10557-020-07084-9 10.1160/TH14-12-1067 10.1253/circj.71.1560 10.1056/nejmra2026131 10.1155/2020/7527953 10.1186/s13054-020-03385-5 10.1183/13993003.01608-2020 10.1093/ehjci/jev014 10.1093/eurheartj/ehab314 10.3389/fcvm.2021.641088 10.3109/10641963.2013.827706 10.1164/rccm.202003-0817LE 10.1183/13993003.00377-2021 10.1016/j.cpcardiol.2020.100742 10.1182/BLOOD.2020006000 10.1007/s00392-020-01800-z 10.1038/s41577-021-00536-9 10.1148/radiol.2020201544 10.1001/jamacardio.2020.1096 10.3389/fmed.2022.863150 10.1016/j.amjmed.2007.10.025 10.3389/fmed.2020.625176 10.1182/blood-2018-11-844530 10.3390/diagnostics11071271 10.1111/eci.13433 10.1182/blood-2004-03-1042 10.1111/jth.14768 10.1126/sciadv.abh2434 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023. The Author(s). |
| Copyright_xml | – notice: The Author(s) 2023 – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023. The Author(s). |
| DBID | C6C AAYXX CITATION 3V. 7RV 7T5 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU FYUFA GHDGH H94 K9. M0R M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY |
| DOI | 10.1007/s11739-023-03383-9 |
| DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Immunology Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Consumer Health Database Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef ProQuest One Academic Middle East (New) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: SpringerLink Open Access Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1970-9366 |
| EndPage | 1993 |
| ExternalDocumentID | 10.1007/s11739-023-03383-9 PMC10543807 10_1007_s11739_023_03383_9 |
| GrantInformation_xml | – fundername: Università degli Studi di Bari Aldo Moro – fundername: ; |
| GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 203 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 40E 53G 5GY 5VS 67Z 6NX 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD AZQEC B-. BA0 BDATZ BENPR BGNMA BKEYQ BKNYI BPHCQ BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG EX3 F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG5 HG6 HLICF HMCUK HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KDC KOV KPH LLZTM M0R M1P M4Y MA- NAPCQ NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOR QOS R89 R9I ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 WOW YLTOR Z45 Z7U Z82 Z83 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PUEGO 7T5 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c452t-6186d54ebdb94ffb78b0a540a528418dca6902daff6a2860f79cc8874e3e7a5c3 |
| IEDL.DBID | BENPR |
| ISSN | 1828-0447 1970-9366 |
| IngestDate | Sun Oct 26 04:04:17 EDT 2025 Tue Sep 30 17:11:17 EDT 2025 Mon Sep 29 04:07:36 EDT 2025 Tue Oct 07 05:59:19 EDT 2025 Wed Oct 01 04:11:18 EDT 2025 Thu Apr 24 23:07:59 EDT 2025 Fri Feb 21 02:41:34 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | Pulmonary embolism SARS-CoV-2 NETosis HMGB1 Immune cells Embolism risk factor |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c452t-6186d54ebdb94ffb78b0a540a528418dca6902daff6a2860f79cc8874e3e7a5c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2293-9698 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://link.springer.com/content/pdf/10.1007/s11739-023-03383-9.pdf |
| PMID | 37592135 |
| PQID | 2870574774 |
| PQPubID | 326318 |
| PageCount | 13 |
| ParticipantIDs | unpaywall_primary_10_1007_s11739_023_03383_9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10543807 proquest_miscellaneous_2853947939 proquest_journals_2870574774 crossref_primary_10_1007_s11739_023_03383_9 crossref_citationtrail_10_1007_s11739_023_03383_9 springer_journals_10_1007_s11739_023_03383_9 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-10-01 |
| PublicationDateYYYYMMDD | 2023-10-01 |
| PublicationDate_xml | – month: 10 year: 2023 text: 2023-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: Milan |
| PublicationSubtitle | Official Journal of the Italian Society of Internal Medicine |
| PublicationTitle | Internal and emergency medicine |
| PublicationTitleAbbrev | Intern Emerg Med |
| PublicationYear | 2023 |
| Publisher | Springer International Publishing Springer Nature B.V |
| Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
| References | Gąsecka, Borovac, Guerreiro (CR15) 2021; 35 D’Alto, Marra, Severino (CR28) 2020 Gómez-Mesa, Galindo-Coral, Montes, Muñoz Martin (CR8) 2021 Tripodi, Chantarangkul, Martinelli (CR18) 2004; 104 Varga, Flammer, Steiger (CR24) 2020; 395 Zakai, Ohira, White (CR16) 2008; 121 Barrett, Cornwell, Myndzar (CR33) 2021 Grillet, Behr, Calame (CR6) 2020; 296 Thomas, Storey (CR32) 2015; 114 Fajgenbaum, June (CR1) 2020; 383 Gattinoni, Coppola, Cressoni (CR31) 2020; 201 Connors, Levy (CR20) 2020; 135 Lang, Badano, Mor-Avi (CR14) 2015; 16 Konstantinides, Meyer, Becattini (CR12) 2019 Sechi, Colussi, Bulfone (CR4) 2021 Te, Chu, Chang (CR35) 2007; 71 Viecca, Radovanovic, Forleo, Santus (CR34) 2020; 158 Haberecker, Schwarz, Steiger (CR23) 2022; 101 Inciardi, Lupi, Zaccone (CR29) 2020; 5 Birnhuber, Fließer, Gorkiewicz (CR10) 2021; 58 Castanheira, Kubes (CR21) 2019; 133 Zhang, Sun, Wu (CR30) 2021; 8 Cicco, Desantis, Vacca (CR13) 2022 Miró, Jiménez, Mebazaa (CR26) 2021; 42 Cicco, Cicco, Racanelli, Vacca (CR11) 2020; 2020 Mozzini, Cicco, Setti (CR5) 2021; 46 Price, McCabe, Garfield, Wort (CR9) 2020 Tang, Li, Wang, Sun (CR7) 2020; 18 Ozkayar, Altun, Yildirim (CR25) 2014; 36 Birocchi, Manzoni, Podda (CR27) 2021; 51 Ozsu, Çoşar, Aksoy (CR17) 2018; 62 Bonaventura, Vecchié, Dagna (CR19) 2021 Cicco, Vacca, Cariddi (CR22) 2021; 11 Solimando, Susca, Borrelli (CR2) 2021 Catena, Colussi, Bulfone (CR3) 2021; 34 JM Connors (3383_CR20) 2020; 135 NA Zakai (3383_CR16) 2008; 121 AG Solimando (3383_CR2) 2021 TJ Barrett (3383_CR33) 2021 JE Gómez-Mesa (3383_CR8) 2021 Z Varga (3383_CR24) 2020; 395 SV Konstantinides (3383_CR12) 2019 LA Sechi (3383_CR4) 2021 M Thomas (3383_CR32) 2015; 114 A Birnhuber (3383_CR10) 2021; 58 M Viecca (3383_CR34) 2020; 158 Ò Miró (3383_CR26) 2021; 42 L Gattinoni (3383_CR31) 2020; 201 LC Price (3383_CR9) 2020 FVS Castanheira (3383_CR21) 2019; 133 RM Inciardi (3383_CR29) 2020; 5 A Bonaventura (3383_CR19) 2021 Y Zhang (3383_CR30) 2021; 8 C Catena (3383_CR3) 2021; 34 S Cicco (3383_CR11) 2020; 2020 F Grillet (3383_CR6) 2020; 296 A Gąsecka (3383_CR15) 2021; 35 C Mozzini (3383_CR5) 2021; 46 S Cicco (3383_CR13) 2022 M D’Alto (3383_CR28) 2020 S Cicco (3383_CR22) 2021; 11 N Ozkayar (3383_CR25) 2014; 36 M Haberecker (3383_CR23) 2022; 101 S Ozsu (3383_CR17) 2018; 62 S Birocchi (3383_CR27) 2021; 51 A Tripodi (3383_CR18) 2004; 104 DC Fajgenbaum (3383_CR1) 2020; 383 RM Lang (3383_CR14) 2015; 16 N Tang (3383_CR7) 2020; 18 HJ Te (3383_CR35) 2007; 71 |
| References_xml | – volume: 101 start-page: 155 year: 2022 end-page: 165 ident: CR23 article-title: Autopsy-based pulmonary and vascular pathology: pulmonary endotheliitis and multi-organ involvement in COVID-19 associated deaths publication-title: Respiration doi: 10.1159/000518914 – volume: 158 start-page: 104950 year: 2020 ident: CR34 article-title: Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study publication-title: Pharmacol Res doi: 10.1016/j.phrs.2020.104950 – volume: 34 start-page: 193 year: 2021 end-page: 195 ident: CR3 article-title: Echocardiographic comparison of COVID-19 patients with or without prior biochemical evidence of cardiac injury after recovery publication-title: J Am Soc Echocardiogr doi: 10.1016/j.echo.2020.10.009 – volume: 46 start-page: 100819 year: 2021 ident: CR5 article-title: Spotlight on cardiovascular scoring systems in Covid-19: severity correlations in real-world setting publication-title: Curr Probl Cardiol doi: 10.1016/j.cpcardiol.2021.100819 – volume: 62 start-page: 1091 year: 2018 end-page: 1096 ident: CR17 article-title: Prognostic value of uric acid for pulmonary thromboembolism publication-title: Respir Care doi: 10.4187/respcare.05433 – volume: 395 start-page: 1417 year: 2020 end-page: 1418 ident: CR24 article-title: Endothelial cell infection and endotheliitis in COVID-19 publication-title: Lancet doi: 10.1016/S0140-6736(20)30937-5 – year: 2019 ident: CR12 article-title: 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz405 – volume: 35 start-page: 215 year: 2021 end-page: 229 ident: CR15 article-title: Thrombotic complications in Patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment publication-title: Cardiovasc Drugs Ther doi: 10.1007/s10557-020-07084-9 – volume: 114 start-page: 449 year: 2015 end-page: 458 ident: CR32 article-title: The role of platelets in inflammation publication-title: Thromb Haemost doi: 10.1160/TH14-12-1067 – volume: 71 start-page: 1560 year: 2007 end-page: 1566 ident: CR35 article-title: Prognostic value of arterial/alveolar oxygen tension ratio (a/APO2) in acute pulmonary embolism publication-title: Circ J doi: 10.1253/circj.71.1560 – volume: 383 start-page: 2255 year: 2020 end-page: 2273 ident: CR1 article-title: Cytokine storm publication-title: N Engl J Med doi: 10.1056/nejmra2026131 – volume: 2020 start-page: 1 year: 2020 end-page: 25 ident: CR11 article-title: Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): two potential targets for COVID-19 treatment publication-title: Mediators Inflamm doi: 10.1155/2020/7527953 – year: 2020 ident: CR28 article-title: Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS publication-title: Crit Care doi: 10.1186/s13054-020-03385-5 – year: 2020 ident: CR9 article-title: Thrombosis and COVID-19 pneumonia: the clot thickens! publication-title: Eur Respir J doi: 10.1183/13993003.01608-2020 – volume: 16 start-page: 233 year: 2015 end-page: 271 ident: CR14 article-title: Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging publication-title: Eur Heart J Cardiovasc Imaging doi: 10.1093/ehjci/jev014 – volume: 42 start-page: 3127 year: 2021 end-page: 3142 ident: CR26 article-title: Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome publication-title: Eur Heart J doi: 10.1093/eurheartj/ehab314 – volume: 8 start-page: 1 year: 2021 end-page: 13 ident: CR30 article-title: Prognostic value of right ventricular ejection fraction assessed by 3D echocardiography in COVID-19 patients publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2021.641088 – volume: 36 start-page: 392 year: 2014 end-page: 397 ident: CR25 article-title: Blood pressure measurements, blood pressure variability and endothelial function in renal transplant recipients publication-title: Clin Exp Hypertens doi: 10.3109/10641963.2013.827706 – volume: 201 start-page: 1299 year: 2020 end-page: 1300 ident: CR31 article-title: COVID-19 does not lead to a “typical” acute respiratory distress syndrome publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202003-0817LE – volume: 58 start-page: 1 year: 2021 end-page: 5 ident: CR10 article-title: Between inflammation and thrombosis: endothelial cells in COVID-19 publication-title: Eur Respir J doi: 10.1183/13993003.00377-2021 – year: 2021 ident: CR8 article-title: Thrombosis and coagulopathy in COVID-19 publication-title: Curr Probl Cardiol doi: 10.1016/j.cpcardiol.2020.100742 – volume: 135 start-page: 2033 year: 2020 end-page: 2040 ident: CR20 article-title: COVID-19 and its implications for thrombosis and anticoagulation publication-title: Blood doi: 10.1182/BLOOD.2020006000 – year: 2021 ident: CR4 article-title: Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge publication-title: Clin Res Cardiol doi: 10.1007/s00392-020-01800-z – year: 2021 ident: CR19 article-title: Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00536-9 – volume: 296 start-page: E186 year: 2020 end-page: E188 ident: CR6 article-title: Acute pulmonary embolism associated with COVID-19 pneumonia detected with pulmonary CT angiography publication-title: Radiology doi: 10.1148/radiol.2020201544 – volume: 5 start-page: 819 year: 2020 end-page: 824 ident: CR29 article-title: Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2020.1096 – year: 2022 ident: CR13 article-title: Cardiovascular risk in patients with takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis publication-title: Front Med doi: 10.3389/fmed.2022.863150 – volume: 121 start-page: 231 year: 2008 end-page: 238 ident: CR16 article-title: Activated partial thromboplastin time and risk of future venous thromboembolism publication-title: Am J Med doi: 10.1016/j.amjmed.2007.10.025 – year: 2021 ident: CR2 article-title: Short-term variations in neutrophil-to-lymphocyte and urea-to-creatinine ratios anticipate intensive care unit admission of COVID-19 patients in the emergency department publication-title: Front Med doi: 10.3389/fmed.2020.625176 – volume: 133 start-page: 2178 year: 2019 end-page: 2185 ident: CR21 article-title: Neutrophils and NETs in modulating acute and chronic inflammation publication-title: Blood doi: 10.1182/blood-2018-11-844530 – volume: 11 start-page: 1271 year: 2021 ident: CR22 article-title: Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of COVID-19 publication-title: Diagnostics doi: 10.3390/diagnostics11071271 – volume: 51 start-page: 1 year: 2021 end-page: 10 ident: CR27 article-title: High rates of pulmonary artery occlusions in COVID-19 publication-title: A meta-analysis Eur J Clin Invest doi: 10.1111/eci.13433 – volume: 104 start-page: 3631 year: 2004 end-page: 3634 ident: CR18 article-title: A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism publication-title: Blood doi: 10.1182/blood-2004-03-1042 – volume: 18 start-page: 844 year: 2020 end-page: 847 ident: CR7 article-title: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia publication-title: J Thromb Haemost doi: 10.1111/jth.14768 – year: 2021 ident: CR33 article-title: Platelets amplify endotheliopathy in COVID-19 publication-title: Sci Adv doi: 10.1126/sciadv.abh2434 – year: 2021 ident: 3383_CR33 publication-title: Sci Adv doi: 10.1126/sciadv.abh2434 – volume: 62 start-page: 1091 year: 2018 ident: 3383_CR17 publication-title: Respir Care doi: 10.4187/respcare.05433 – volume: 18 start-page: 844 year: 2020 ident: 3383_CR7 publication-title: J Thromb Haemost doi: 10.1111/jth.14768 – year: 2019 ident: 3383_CR12 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz405 – volume: 36 start-page: 392 year: 2014 ident: 3383_CR25 publication-title: Clin Exp Hypertens doi: 10.3109/10641963.2013.827706 – volume: 71 start-page: 1560 year: 2007 ident: 3383_CR35 publication-title: Circ J doi: 10.1253/circj.71.1560 – volume: 201 start-page: 1299 year: 2020 ident: 3383_CR31 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202003-0817LE – year: 2020 ident: 3383_CR9 publication-title: Eur Respir J doi: 10.1183/13993003.01608-2020 – volume: 51 start-page: 1 year: 2021 ident: 3383_CR27 publication-title: A meta-analysis Eur J Clin Invest doi: 10.1111/eci.13433 – volume: 16 start-page: 233 year: 2015 ident: 3383_CR14 publication-title: Eur Heart J Cardiovasc Imaging doi: 10.1093/ehjci/jev014 – year: 2021 ident: 3383_CR2 publication-title: Front Med doi: 10.3389/fmed.2020.625176 – volume: 158 start-page: 104950 year: 2020 ident: 3383_CR34 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2020.104950 – volume: 395 start-page: 1417 year: 2020 ident: 3383_CR24 publication-title: Lancet doi: 10.1016/S0140-6736(20)30937-5 – volume: 58 start-page: 1 year: 2021 ident: 3383_CR10 publication-title: Eur Respir J doi: 10.1183/13993003.00377-2021 – year: 2021 ident: 3383_CR19 publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00536-9 – volume: 42 start-page: 3127 year: 2021 ident: 3383_CR26 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehab314 – year: 2020 ident: 3383_CR28 publication-title: Crit Care doi: 10.1186/s13054-020-03385-5 – volume: 11 start-page: 1271 year: 2021 ident: 3383_CR22 publication-title: Diagnostics doi: 10.3390/diagnostics11071271 – volume: 5 start-page: 819 year: 2020 ident: 3383_CR29 publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2020.1096 – volume: 121 start-page: 231 year: 2008 ident: 3383_CR16 publication-title: Am J Med doi: 10.1016/j.amjmed.2007.10.025 – volume: 34 start-page: 193 year: 2021 ident: 3383_CR3 publication-title: J Am Soc Echocardiogr doi: 10.1016/j.echo.2020.10.009 – volume: 46 start-page: 100819 year: 2021 ident: 3383_CR5 publication-title: Curr Probl Cardiol doi: 10.1016/j.cpcardiol.2021.100819 – volume: 2020 start-page: 1 year: 2020 ident: 3383_CR11 publication-title: Mediators Inflamm doi: 10.1155/2020/7527953 – volume: 104 start-page: 3631 year: 2004 ident: 3383_CR18 publication-title: Blood doi: 10.1182/blood-2004-03-1042 – year: 2021 ident: 3383_CR4 publication-title: Clin Res Cardiol doi: 10.1007/s00392-020-01800-z – volume: 383 start-page: 2255 year: 2020 ident: 3383_CR1 publication-title: N Engl J Med doi: 10.1056/nejmra2026131 – volume: 35 start-page: 215 year: 2021 ident: 3383_CR15 publication-title: Cardiovasc Drugs Ther doi: 10.1007/s10557-020-07084-9 – volume: 101 start-page: 155 year: 2022 ident: 3383_CR23 publication-title: Respiration doi: 10.1159/000518914 – volume: 8 start-page: 1 year: 2021 ident: 3383_CR30 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2021.641088 – year: 2022 ident: 3383_CR13 publication-title: Front Med doi: 10.3389/fmed.2022.863150 – volume: 114 start-page: 449 year: 2015 ident: 3383_CR32 publication-title: Thromb Haemost doi: 10.1160/TH14-12-1067 – volume: 133 start-page: 2178 year: 2019 ident: 3383_CR21 publication-title: Blood doi: 10.1182/blood-2018-11-844530 – volume: 135 start-page: 2033 year: 2020 ident: 3383_CR20 publication-title: Blood doi: 10.1182/BLOOD.2020006000 – volume: 296 start-page: E186 year: 2020 ident: 3383_CR6 publication-title: Radiology doi: 10.1148/radiol.2020201544 – year: 2021 ident: 3383_CR8 publication-title: Curr Probl Cardiol doi: 10.1016/j.cpcardiol.2020.100742 |
| SSID | ssj0055617 |
| Score | 2.3367696 |
| Snippet | COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has... |
| SourceID | unpaywall pubmedcentral proquest crossref springer |
| SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 1981 |
| SubjectTerms | Alveoli Biopsy Blood gas analysis Blood pressure CD3 antigen CD4 antigen CD8 antigen Computed tomography COVID-19 COVID-19 : diagnosis Embolism HMGB1 protein Im - Original Internal Medicine management and prognosis Medicine Medicine & Public Health Oxygen Pulmonary embolisms Risk factors |
| SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSDwOFU-x0KJB4kYtnMSOY25o26pFAi4U9RbZcayulGZXuxuhXvjtzLhJlq1QBWc7dpJv7JnxjL9h7J1MtXFSau4yH7jMk8BtEQquhbDaCOG0jdkWX_OTM_n5XJ33NDl0F-ZG_P7DKkl0ZjhqFi7Im-LmLruHSiqPgdl8Ouy6VOUxFlIpiHEZJ-8vyPx9jG0ltLEsb-ZFjsHRR-xB1y7s1U_bNH_on-PHbLc3HOHTNdJP2J26fcruf-lD48_Yr1O66VGDR9y6pSMwoUEAV7Cew6JrUNzs8grqSzdvZqtLmLUw_fbj9JAnBijZFugMHSoypgk3oJxz6KvxfAQLwxVKsK2HyFLc75oQGWqfs7Pjo-_TE94XV-CVVOmaE0--V7J23hkZgtOFExbNN6tQYSWFryz6zam3IeQ2LXIRtKkq3JFkndXaqip7wXbaeVu_ZKC9qVRIlBc-SB9wIDQ6hQheGo8OWJiwZPjbZdUzj1MBjKbccCYTQiUiVEaESjNh78dnFte8G7f23htALPs1uCophKvQW9Jywt6Ozbh6KCRi23reUR-VGTpcxCGKLfDHWYl_e7ulnV1EHm40TSNf_4QdDHKymf22lz0YZekfvu3V_43-mj1MSdJjvuEe21kvu3of7aa1exMXzG-fzg4J priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NTuLjgc8hCgMZiTfmzknsOOZt2pg2JAYPFI2nyI5tUZGlVZsIjQf-dnxp0tIJTSCe7Tix87Pvznf3O4BXPJbKcC6pSaynPI081ZnPqGRMS8WYkbqNtjhLT8b83bk434KjPhemjXbvXZLLnAZkaarq_Zn1--vEt0gmigZ5QxnaWFSNQvMN2E5F0MgHsD0--3jwBW2tDAmYeVtnLFKSUZWkaZc78-eBNuXTWum8GjK58pvegVtNNdOX33VZ_iaaju-B6ye1jEj5NmpqMyp-XOF7_N9Z34e7ne5KDpZgewBbrnoIN9933vlH8PMUk00csQE6zdwgnkgZMLQg9ZTMmjIgXs8vibsw03KyuCCTihx--Hx6RCNFMN6X4DU-KVCfR-gQDHsnXUGgN0STPouT6MqSlii5O7hJS5K7A-Pjt58OT2hX34EWXMQ1Rap-K7gz1ijuvZGZYTpokFoEmRllttDBdI-t9j7VcZYyL1VRhEORu8RJLYrkMQyqaeWeAJFWFcJHwjLrufVhoKD3MuYtVzbYgH4IUf9X86IjP8caHGW-pm3Gxc3D4ubt4uZqCK9Xz8yW1B_X9t7twZJ3x8AiRy-yCAab5EN4uWoOGxi9Mrpy0wb7iETh_WYYItsA2eqtSAG-2VJNvrZU4EE7bksGDGGvh8_67dd97N4Ks38xt6f_1v0Z3I4RpG3I4y4M6nnjngfVrTYvup35C1hxOqc priority: 102 providerName: Unpaywall |
| Title | Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study |
| URI | https://link.springer.com/article/10.1007/s11739-023-03383-9 https://www.proquest.com/docview/2870574774 https://www.proquest.com/docview/2853947939 https://pubmed.ncbi.nlm.nih.gov/PMC10543807 https://link.springer.com/content/pdf/10.1007/s11739-023-03383-9.pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1970-9366 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0055617 issn: 1828-0447 databaseCode: AFBBN dateStart: 20060401 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 1970-9366 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0055617 issn: 1828-0447 databaseCode: 7X7 dateStart: 20060401 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1970-9366 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0055617 issn: 1828-0447 databaseCode: BENPR dateStart: 20060401 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1970-9366 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0055617 issn: 1828-0447 databaseCode: AGYKE dateStart: 20060101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1970-9366 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0055617 issn: 1828-0447 databaseCode: U2A dateStart: 20060401 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwEB7tthKPA-K1orBURuLGWiSpU8dICLWlZRdEWSGKuqfIiWNRKZuUthHaC7-dmTRJKYeKSyPVeTnfeDz2zHwD8FJ4UkVCSB71jOWi71quAxtw6ThaKseJpC6jLab985n4OPfnRzCtc2EorLLWiaWiNnlMe-SvySHno-0rxbvlT05Vo8i7WpfQ0FVpBfO2pBg7hrZHzFgtaA_H08uvtW6mWpBluZWAeJnxFas0mm0ynSt7iuMcxh1at3G1P1Xt7M9_oycbF-pduF1kS33zS6fpX7PU5D7cq8xLNtjKwwM4SrKHcOtz5UB_BL8vKB8kYQbRLVYRQc5ShHnNNjlbFin2Uq9uWHId5elifc0WGRt9-X7xnruKUUguo512FpPJTegyikxnVc2eN0yzOtGS6cywksu40q2s5LF9DLPJ-NvonFclGHgsfG_DiU3f-CKJTKSEtZEMIkejkad9nNbcwMQaV9ee0db2tRf0HStVHKPeEkkvkdqPeyfQyvIseQJMGhX71vWNY6wwFm-EpqnjWCOUwWWa7YBbf-0wrvjJqUxGGu6YlQmhEBEKS4RC1YFXzTXLLTvHwbNPaxDDaqSuw51cdeBF04xjjBwnOkvygs7xe4q2IPEWwR74zVOJpXu_JVv8KNm60YAtWf07cFbLye7ph172rJGl_-jb08N9ewZ3PJLsMgrxFFqbVZE8R2tqE3XhWM5lF9qDyXA4peOHq0_jbjVwsHXUH-HvzBvgf7Pp5eDqDzMDIzo |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGJjF4QHyKwgAjwROzcBKnjpEmBPtQy7aC0Ib2Fuw4FpWytLSNpr7wp_G3cZc6KeWh4mXPSZzEdz7f-e5-P0JeiVAqI4RkJrKOiW7gmE5cwiTnWirOjdR1tcWg2zsXny7iiw3yu-mFwbLKxibWhtqOMjwjf4sJuRh8Xynej38yZI3C7GpDoaE9tYLdqyHGfGPHcT6_ghBuutc_AHm_DsOjw7P9HvMsAywTcThjCBhvY5Eba5RwzsjEcA1-jI7BcgeJzTQEkKHVznV1mHS5kyrLYGmKPMqljrMIxr1BtkQkFAR_Wx8PB1--NnsBck_W9C4J4kDDlPi2nUXzXiAjxWDPZBzjRKZWt8alv_tvtWabsr1NtqtyrOdXuij-2hWP7pI73p2lHxb6d49s5OV9cvPUJ-wfkF997D_JqQVtqiYGVYwWoFZTOhvRcVXArOrJnOaXZlQMp5d0WNL9z9_6ByxQFEuAKZ7s0wxdfNQmipXw1HMEvaOaNo2dVJeW1tjJ3pbTGjf3ITm_FmE8IpvlqMwfEyqtymIXxJZbJ6yDgcAV5txZoSyEha5Dgma208zjoSMtR5EukZxRQilIKK0llKoOedM-M16ggay9e6cRYuotwzRd6nGHvGwvw5rGRI0u81GF98SRwiNPGCJZEX77VkQFX71SDn_U6ODgMNcsAh2y2-jJ8u3rPna31aX_-Lcn6__tBdnunZ2epCf9wfFTcitELa8rIHfI5mxS5c_Ak5uZ5365UPL9ulfoH2h4WW0 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLfGkAYcEJ-iMMBIcGLWnMSpYySE0Eq1MhgcGOots-NYVMqS0jaaeuEP46_jPTdJKYeKy85OnNjv957f8_si5KUIpTJCSGYi65joB47pxCVMcq6l4txI7aMtTvvHZ-LjOB7vkN9tLgyGVbYy0QtqW2V4R36IDrkYdF8pDl0TFvF1MHw3_cmwgxR6Wtt2GiuInOTLSzDf5m9HA6D1qzAcfvh2dMyaDgMsE3G4YFgs3sYiN9Yo4ZyRieEadBgdg9QOEptpMB5Dq53r6zDpcydVlgFbijzKpY6zCOa9Rq7LKFIYTijHnbGHXSd9Y5cEK0DDZjQJO6u0vUBGisFpyThaiExtHoprTfffOM3OWXuL3KjLqV5e6qL46zwc3iG3G0WWvl8h7y7Zyct7ZO9z46q_T36NMPMkpxZwVM8MgosWAKg5XVR0Whewh3q2pPmFqYrJ_IJOSnr05ftowAJFMfiX4p0-zVC5RxxRjIGnTXegN1TTNqWT6tJSXzW5keLUV8x9QM6uhBQPyW5ZlfkjQqVVWeyC2HLrhHUwESjBnDsrlAWD0PVI0O52mjWV0LEhR5GuazgjhVKgUOoplKoeed29M13VAdn69H5LxLSRCfN0jeAeedENAzeji0aXeVXjM3Gk8LITpkg2iN99FeuBb46Ukx--Ljioyr5_QI8ctDhZf33bzx50WPqPtT3evrbnZA_4Mv00Oj15Qm6GCHIf-rhPdhezOn8KKtzCPPO8Qsn5VTPnH-4WVwc |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NTuLjgc8hCgMZiTfmzknsOOZt2pg2JAYPFI2nyI5tUZGlVZsIjQf-dnxp0tIJTSCe7Tix87Pvznf3O4BXPJbKcC6pSaynPI081ZnPqGRMS8WYkbqNtjhLT8b83bk434KjPhemjXbvXZLLnAZkaarq_Zn1--vEt0gmigZ5QxnaWFSNQvMN2E5F0MgHsD0--3jwBW2tDAmYeVtnLFKSUZWkaZc78-eBNuXTWum8GjK58pvegVtNNdOX33VZ_iaaju-B6ye1jEj5NmpqMyp-XOF7_N9Z34e7ne5KDpZgewBbrnoIN9933vlH8PMUk00csQE6zdwgnkgZMLQg9ZTMmjIgXs8vibsw03KyuCCTihx--Hx6RCNFMN6X4DU-KVCfR-gQDHsnXUGgN0STPouT6MqSlii5O7hJS5K7A-Pjt58OT2hX34EWXMQ1Rap-K7gz1ijuvZGZYTpokFoEmRllttDBdI-t9j7VcZYyL1VRhEORu8RJLYrkMQyqaeWeAJFWFcJHwjLrufVhoKD3MuYtVzbYgH4IUf9X86IjP8caHGW-pm3Gxc3D4ubt4uZqCK9Xz8yW1B_X9t7twZJ3x8AiRy-yCAab5EN4uWoOGxi9Mrpy0wb7iETh_WYYItsA2eqtSAG-2VJNvrZU4EE7bksGDGGvh8_67dd97N4Ks38xt6f_1v0Z3I4RpG3I4y4M6nnjngfVrTYvup35C1hxOqc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immune+disturbance+leads+to+pulmonary+embolism+in+COVID-19+more+than+classical+risk+factors%3A+a+clinical+and+histological+study&rft.jtitle=Internal+and+emergency+medicine&rft.au=Cicco%2C+Sebastiano&rft.au=Vacca%2C+Antonio&rft.au=Albanese%2C+Federica&rft.au=Susca%2C+Nicola&rft.date=2023-10-01&rft.issn=1828-0447&rft.eissn=1970-9366&rft.volume=18&rft.issue=7&rft.spage=1981&rft.epage=1993&rft_id=info:doi/10.1007%2Fs11739-023-03383-9&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11739_023_03383_9 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1828-0447&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1828-0447&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1828-0447&client=summon |